• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: Post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials.

作者信息

Verma Subodh, Husain Mansoor, Madsen Christian M, Leiter Lawrence A, Kuhlman Anja Birk, Vilsbøll Tina, Rasmussen Søren, Libby Peter

机构信息

St. Michael's Hospital of Unity Health Toronto, Toronto, Ontario, Canada.

Ted Rogers Centre for Heart Research, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

出版信息

Diabetes Obes Metab. 2023 Aug;25(8):2398-2401. doi: 10.1111/dom.15088. Epub 2023 May 8.

DOI:10.1111/dom.15088
PMID:37046366
Abstract
摘要

相似文献

1
Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: Post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials.中性粒细胞与淋巴细胞比值可预测2型糖尿病患者的心血管事件：SUSTAIN 6和PIONEER 6心血管结局试验的事后分析
Diabetes Obes Metab. 2023 Aug;25(8):2398-2401. doi: 10.1111/dom.15088. Epub 2023 May 8.
2
Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of double-blind, randomized, placebo-controlled clinical trials.胰高血糖素样肽-1（GLP-1）受体激动剂与 2 型糖尿病患者的心血管事件：一项双盲、随机、安慰剂对照临床试验的荟萃分析。
BMC Endocr Disord. 2022 May 12;22(1):125. doi: 10.1186/s12902-022-01036-0.
3
Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: Is It a Class Effect?胰高血糖素样肽-1 受体激动剂与 2 型糖尿病患者的心血管风险降低：这是一类药物的作用吗？
Curr Cardiol Rep. 2018 Sep 26;20(11):113. doi: 10.1007/s11886-018-1051-2.
4
Semaglutide reduces the risk of major adverse cardiovascular events consistently across baseline triglyceride levels in patients with type 2 diabetes: Post hoc analyses of the SUSTAIN 6 and PIONEER 6 trials.司美格鲁肽在2型糖尿病患者中，无论基线甘油三酯水平如何，均能持续降低主要不良心血管事件风险：SUSTAIN 6和PIONEER 6试验的事后分析
Diabetes Obes Metab. 2023 Aug;25(8):2388-2392. doi: 10.1111/dom.15081. Epub 2023 May 3.
5
Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk.司美格鲁肽（SUSTAIN 和 PIONEER）降低了不同心血管风险的 2 型糖尿病患者的心血管事件风险。
Diabetes Obes Metab. 2020 Mar;22(3):442-451. doi: 10.1111/dom.13955. Epub 2020 Feb 5.
6
Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials.胰高血糖素样肽-1受体激动剂对伴或不伴已确诊心血管疾病的2型糖尿病患者主要心血管事件的影响：一项随机对照试验的荟萃分析
Eur Heart J. 2020 Sep 14;41(35):3346-3358. doi: 10.1093/eurheartj/ehaa082.
7
Glucagon-like Peptide-1 Receptor Agonists Cardio-protective Effects: An Umbrella Review.胰高血糖素样肽-1受体激动剂的心脏保护作用：一项系统评价。
Curr Diabetes Rev. 2020;16(8):820-832. doi: 10.2174/1573399816666200522214554.
8
Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6.司美格鲁肽可降低心血管事件风险，无论是否使用二甲双胍：SUSTAIN 6 和 PIONEER 6 的事后亚组分析。
Cardiovasc Diabetol. 2022 Apr 28;21(1):64. doi: 10.1186/s12933-022-01489-6.
9
Oral semaglutide in patients with type 2 diabetes and cardiovascular disease, renal impairment, or other comorbidities, and in older patients.口服司美格鲁肽在伴有心血管疾病、肾功能损害或其他合并症的 2 型糖尿病患者以及老年患者中的应用。
Postgrad Med. 2020 Nov;132(sup2):37-47. doi: 10.1080/00325481.2020.1800286. Epub 2020 Sep 8.
10
Effects of glucagon-like peptide-1 receptor agonists on cardiovascular and renal outcomes: A meta-analysis and meta-regression analysis.胰高血糖素样肽-1 受体激动剂对心血管和肾脏结局的影响：一项荟萃分析和荟萃回归分析。
Diabetes Obes Metab. 2022 Jun;24(6):1029-1037. doi: 10.1111/dom.14666. Epub 2022 Feb 21.

引用本文的文献

1
Association between advanced lung cancer inflammation index and all-cause and cause-specific mortality among asthma patients: a cohort study.哮喘患者中晚期肺癌炎症指数与全因死亡率及特定病因死亡率的关联：一项队列研究
Front Nutr. 2025 Feb 6;12:1519271. doi: 10.3389/fnut.2025.1519271. eCollection 2025.
2
Association of neutrophil-to-lymphocyte ratio with all-cause and cardiovascular mortality in CVD patients with diabetes or pre-diabetes.中性粒细胞与淋巴细胞比值与合并糖尿病或糖尿病前期的心血管疾病患者全因及心血管死亡率的相关性。
Sci Rep. 2024 Oct 17;14(1):24324. doi: 10.1038/s41598-024-74642-8.
3
Relationship of the Neutrophil-Lymphocyte Ratio with All-Cause and Cardiovascular Mortality in Patients with Diabetic Kidney Disease: A Prospective Cohort Study of NHANES Study.
糖尿病肾病患者中性粒细胞与淋巴细胞比值与全因死亡率和心血管死亡率的关系：一项基于美国国家健康与营养检查调查（NHANES）的前瞻性队列研究
J Multidiscip Healthc. 2024 May 21;17:2461-2473. doi: 10.2147/JMDH.S465317. eCollection 2024.
4
Inflammaging and Blood Pressure Profiles in Late Life: The Screening for CKD among Older People across Europe (SCOPE) Study.老年人群的炎症衰老与血压特征：欧洲老年人慢性肾脏病筛查（SCOPE）研究
J Clin Med. 2022 Dec 9;11(24):7311. doi: 10.3390/jcm11247311.